Abstract
Previous comparative genomic hybridization and allelic loss analyses demonstrated frequent deletions from 15q11.1–15 in malignant mesothelioma. Recurrent losses of 15q11–22 have also been reported in several other tumor types such as breast and colorectal cancers. To more precisely map the commonly deleted region, we have performed a high density loss of heterozygosity analysis of 46 malignant mesotheliomas, using 26 polymorphic microsatellite markers spanning the entire long arm of chromsome 15. Allelic loss from 15q was observed in 22 of 46 (48%) cases. These analyses have defined a minimally deleted region of ∼3-cM, which was confirmed to reside at 15q15 by fluorescence in situ hybridization analysis with yeast artificial chromosome probes. No tumor suppressor genes have been reported to map to this site. The minimally deleted region identified in this investigation overlaps those observed in other kinds of cancer, and is the smallest site of recurrent 15q loss identified to date in human tumors. The identification of this commonly deleted site implicates a putative tumor suppressor gene(s) at 15q15 involved in diverse forms of human neoplasia.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Altomare DA, Kozak CA, Sonoda G, Testa JR . 1996 Cytogenet. Cell Genet. 74: 248–251
Antman KH . 1981 Semin. Oncol. 8: 313–320
Antman KH, Li FP, Osteen R, Sugarbaker DJ . 1989 Mesothelioma J.B. Lippincott Co, Philadelphia
Attanoos RL, Gibbs AR . 1997 Histopathology 30: 403–418
Balsara BR, Bell DW, Sonoda G, De Rienzo A, du Manoir S, Jhanwar SC, Testa JR . 1999 Cancer Res. 59: 450–454
Bell DW, Jhanwar SC, Testa JR . 1997 Cancer Res. 57: 4057–4062
Bianchi AB, Mitsunaga SI, Cheng JQ, Klein WM, Jhanwar SC, Seizinger B, Kley N, Klein-Szanto AJ, Testa JR . 1995 Proc. Natl. Acad. Sci. USA 92: 10854–10858
Bisconti M, Bisetti A, Bidoli P . 2000 Respiration 67: 223–228
Bjorkqvist AM, Tammilehto L, Anttila S, Mattson K, Knuutila S . 1997 Br. J. Cancer 75: 523–527
Bjorkqvist AM, Wolf M, Nordling S, Tammilehto L, Knuuttila A, Kere J, Mattson K, Knuutila S . 1999 Br. J. Cancer 81: 1111–1115
Broman KW, Murray JC, Sheffield VC, White RL, Weber JL . 1998 Am. J. Hum. Genet. 63: 861–869
Carbone M, Fisher S, Powers A, Pass HI, Rizzo P . 1999 J. Cell. Physiol. 180: 167–172
Cheng JQ, Jhanwar SC, Klein WM, Bell DW, Lee WC, Altomare DA, Nobori T, Olopade OI, Buckler AJ, Testa JR . 1994 Cancer Res. 54: 5547–5551
Cheng JQ, Lee WC, Klein MA, Cheng GZ, Jhanwar SC, Testa JR . 1999 Genes Chromosomes Cancer 24: 238–242
Collins A, Teague J, Keats BJ, Morton NE . 1996 Genomics 36: 157–162
Craighead JE, Mossman BT . 1982 N. Engl. J. Med. 306: 1446–1455
De Rienzo A, Jhanwar SC, Testa JR . 2000 Genes Chromosomes Cancer 28: 337–341
Dodson MK, Hartmann LC, Cliby WA, DeLacey KA, Keeney GL, Ritland SR, Su JQ, Podratz KC, Jenkins RB . 1993 Cancer Res. 53: 4456–4460
Kersemaekers AM, Kenter GG, Hermans J, Fleuren GJ, van de Vijver MJ . 1998 Int. J. Cancer 79: 411–417
Knudson AG . 1989 Cancer 63: 1888–1891
Lynch HT, Katz D, Markvicka SE . 1985 Cancer Genet. Cytogenet. 15: 25–35
Mossman BT, Kamp DW, Weitzman SA . 1996 Cancer Invest. 14: 466–480
Olson TM, Michels VV, Thibodeau SN, Tai YS, Keating MT . 1998 Science 280: 750–752
Pache JC, Janssen YM, Walsh ES, Quinlan TR, Zanella CL, Low RB, Taatjes DJ, Mossman BT . 1998 Am. J. Pathol. 152: 333–340
Park WS, Park JY, Oh RR, Yoo NJ, Lee SH, Shin MS, Lee HK, Han S, Yoon SK, Kim SY, Choi C, Kim PJ, Oh ST, Lee JY . 2000 Cancer Res. 60: 70–73
Popescu NC, Chahinian AP, DiPaolo JA . 1988 Cancer Res. 48: 142–147
Schmutte C, Tombline G, Rhiem K, Sadoff MM, Schmutzler R, von Deimling A, Fischel R . 1999 Cancer Res. 59: 4564–4569
Seemayer TA, Cavenee WK . 1989 Lab. Invest. 60: 585–599
Sekido Y, Pass HI, Bader S, Mew DJ, Christman MF, Gazdar AF, Minna JD . 1995 Cancer Res. 55: 1227–1231
Shivapurkar N, Virmani AK, Wistuba II, Milchgrub S, Mackay B, Minna JD, Gazdar AF . 1999 Clin. Cancer Res. 5: 17–23
Stanton SE, Shin SW, Johnson BE, Meyerson M . 2000 Genes Chromosomes Cancer 27: 323–331
Taguchi T, Jhanwar SC, Siegfried JM, Keller SM, Testa JR . 1993 Cancer Res. 53: 4349–4355
Tahara H, Smith AP, Gas RD, Cryns VL, Arnold A . 1996 Cancer Res. 56: 599–605
Testa JR, Carbone M, Hirvonen A, Khalili K, Krynska B, Linnainmaa K, Pooley FD, Rizzo P, Rusch V, Xiao GH . 1998 Cancer Res. 58: 4505–4509
Tomlinson I, Rahman N, Frayling I, Mangion J, Barfoot R, Hamoudi R, Seal S, Northover J, Thomas HJ, Neale K, Hodgson S, Talbot I, Houlston R, Stratton MR . 1999 Gastroenterology 116: 789–795
Weinberg R . 1993 Neuron 11: 191–196
Wick W, Petersen I, Schmutzler RK, Wolfarth B, Lenartz D, Bierhoff E, Hummerich J, Muller DJ, Stangl AP, Schramm J, Wiestler OD, von Deimling A . 1996 Oncogene 12: 973–978
Acknowledgements
This investigation was supported by National Cancer Institute Grants CA-45745 and CA-06927, by a gift from the Local #14 Mesothelioma Fund of the International Association of Heat and Frost Insulators & Asbestos Workers in memory of Hank Vaughan and Alice Haas, and by an appropriation from the Commonwealth of Pennsylvania.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
De Rienzo, A., Balsara, B., Apostolou, S. et al. Loss of heterozygosity analysis defines a 3-cM region of 15q commonly deleted in human malignant mesothelioma. Oncogene 20, 6245–6249 (2001). https://doi.org/10.1038/sj.onc.1204828
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1204828
Keywords
This article is cited by
-
Gene expression profiling of homologous recombination repair pathway indicates susceptibility for olaparib treatment in malignant pleural mesothelioma in vitro
BMC Cancer (2019)
-
Frequent loss of heterozygosity in the β2-microglobulin region of chromosome 15 in primary human tumors
Immunogenetics (2011)
-
Curcumin suppresses growth of mesothelioma cells in vitro and in vivo, in part, by stimulating apoptosis
Molecular and Cellular Biochemistry (2011)
-
Loss of heterozygosity at 15q21.3 correlates with occurrence of metastases in head and neck cancer
Modern Pathology (2006)